J. Vergnon

Estimation of the risk for nutritional state degradation in patients with cancer: development of a screening tool based on results from a cross-sectional survey.

J. Vergnon, F. Chauvin, P. Michaud, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Raynaud's phenomenon of the lung. A reality both in primary and secondary Raynaud syndrome.

J. Vergnon, J. Barthélémy, C. Boissier, 1992, Chest.

Activated lung lymphocytes in hypersensitivity pneumonitis.

J. Vergnon, J. Revillard, J. Mornex, 1984, The Journal of allergy and clinical immunology.

Therapeutic bronchoscopy for malignant central airway obstruction: Introduction to the EpiGETIF registry

J. Dutilh, A. Briault, F. Wallyn, 2024, Respirology.

Efficacy of tracheal and bronchial stent placement on respiratory functional tests.

F Costes, J. Vergnon, F. Costes, 1995, Chest.

Development of a protocol of isolation of nanoparticles from patients' broncho-alveolar lavages for their in vitro toxicity assessment

V. Forest, L. Leclerc, J. Vergnon, 2023, Nanoscale advances.

[Bench-test evaluation of spacer devices for fluticasone delivery to infants].

L. Leclerc, G. Sarry, Jean-Christophe Dubus, 2017, Revue des maladies respiratoires.

Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for

G. Karpathiou, V. Yvorel, M. Stachowicz, 2016 .

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

E. Touboul, T. Molina, E. Lemarié, 2003, British Journal of Cancer.